Assessment of the U.S. Food and Drug Administration's risk evaluation and mitigation strategy (REMS) for prasugrel (EFFIENT): A narrative review
- Resource Type
- Article
- Source
- In
American Heart Journal Plus: Cardiology Research and Practice February 2024 38 - Subject
- Language
- ISSN
- 2666-6022